Senate Passes Marijuana Amendment While Trump and Sessions Try to Stop It

With Marijuana state laws threatened, a new amendment could potentially help to give states the rights they deserve. Occurring on July 27th, Senator Patrick Leahy (D-VT) went to the Senate and successfully proposed and passed the Rohrabacher-Blumenauer amendment in the Senate Appropriations Committee which will protect lawful medical marijuana programs from being impeded upon by the Dept. of Justice.

DOJA Cannabis Company Receives Conditional Approval of CSE Listing

SG Spirit Gold Inc. is pleased to announce that it has received conditional approval from the Canadian Securities Exchange with respect to the proposed three-cornered amalgamation  between the Company, Northern Lights Marijuana Company Limited ("DOJA") and a wholly-owned subsidiary of the Company.

Industry Leaders Riding High as Marijuana Demand Outpaces Supply

Industry Leaders Riding High as Marijuana Demand Outpaces Supply NetworkNewsWire Editorial Coverage Share this article NEW YORK , July 19, The legal marijuana market has been growing by leaps and bounds in North America . Sales jumped 30 percent in 2016, accounting for $6.7 billion in retail activity in the United States and Canada .

MedReleaf Corp. Announces Distribution Agreement with CannaKorp Inc.

MedReleaf Corp. ( TSX: LEAF ), North America's first and only ISO 9001 and ICH-GMP certified producer of cannabis-based pharmaceutical products, today announced a multi-year licensing and distribution agreement with Massachusetts -based CannaKorp Inc. ("CannaKorp"), makers of the world's first single-use, pod-based cannabis vaporizing system, the CannaCloud™. 

Medical Marijuana, Inc. Announces Largest Revenue Quarter and Sales Month in Company History, 269% Revenue Increase From Q2 2016

Medical Marijuana, Inc. (OTC: MJNA), the first-ever publicly traded cannabis company in the United States , today announced that the second quarter of 2017 generated the largest revenue quarter in the Company's history. Additionally, the Company celebrated the largest-ever single month of revenue in June 2017 as well as the largest sales month and quarter for wholly owned subsidiary Kannaway.

Cannabis Science Releases its 2017 Guidance Report for 2nd Quarter 2017, and Outlines Company's Performance and Growth Opportunities as the Medical Cannabis Industry Expands Dramatically

Cannabis Science, Inc. (OTC PINK: CBIS), a U.S. company specializing in the development of cannabinoid-based medicines, is pleased to announce that the Company has already achieved a good number of its goals for 2017. Cannabis Science is aggressively expanding its corporate footprint in legal states throughout the USA, to help self-medicating patients with multiple critical ailments.